$192 Million is the total value of Altium Capital Management LP's 72 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 79.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $3,834,090 | -27.3% | 117,000 | -21.9% | 2.00% | -49.9% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $1,111,500 | -32.2% | 650,000 | -54.4% | 0.58% | -53.2% |
| FATBW | Sell | FAT BRANDS INC*w exp 07/16/202 | $974,000 | +25.5% | 200,000 | -11.9% | 0.51% | -13.6% |
| Sell | GRI BIO INC | $808,337 | -83.9% | 521,508 | -55.8% | 0.42% | -88.9% | |
| Sell | BRUUSH ORAL CARE INC*w exp 08/03/202 | $342 | -98.8% | 14,423 | -96.0% | 0.00% | -100.0% | |
| ZEVWS | Exit | LIGHTNING EMOTORS INC*w exp 05/18/202 | $0 | – | -32,608 | -100.0% | -0.00% | – |
| Exit | MURPHY CANYON ACQUISITION CO*w exp 01/25/202 | $0 | – | -100,000 | -100.0% | -0.00% | – | |
| CLBRWS | Exit | COLOMBIER ACQUISITION CORP*w exp 99/99/999 | $0 | – | -16,666 | -100.0% | -0.01% | – |
| Exit | FIBROGEN INCput | $0 | – | -17,000 | -100.0% | -0.04% | – | |
| Exit | FIBROGEN INCcall | $0 | – | -35,000 | -100.0% | -0.07% | – | |
| Exit | MARPAI INC | $0 | – | -117,848 | -100.0% | -0.15% | – | |
| GOED | Exit | POLISHED COM INC | $0 | – | -576,048 | -100.0% | -0.20% | – |
| GOEDWS | Exit | POLISHED COM INC*w exp 06/02/202 | $0 | – | -6,103,824 | -100.0% | -0.30% | – |
| Exit | OPY ACQUISITION CORP I | $0 | – | -50,000 | -100.0% | -0.39% | – | |
| CLBR | Exit | COLOMBIER ACQUISITION CORPcl a | $0 | – | -50,000 | -100.0% | -0.39% | – |
| Exit | MERSANA THERAPEUTICS INCcall | $0 | – | -200,100 | -100.0% | -0.50% | – | |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -35,100 | -100.0% | -0.50% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -150,000 | -100.0% | -0.78% | – |
| Exit | WESTERN ACQSTN VENTURES CORP | $0 | – | -100,000 | -100.0% | -0.79% | – | |
| Exit | PEPPERLIME HEALTH ACQUSTN CO | $0 | – | -100,000 | -100.0% | -0.79% | – | |
| Exit | BRIDGEBIO PHARMA INCput | $0 | – | -200,000 | -100.0% | -2.60% | – | |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS IN | $0 | – | -323,000 | -100.0% | -2.70% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -41,485 | -100.0% | -3.20% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -305,000 | -100.0% | -8.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 12 | Q3 2023 | 0.6% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| BELLUS HEALTH INC NEW | 10 | Q1 2023 | 4.7% |
| XTANT MED HLDGS INC | 10 | Q3 2023 | 5.1% |
| IVERIC BIO INC | 10 | Q1 2023 | 2.3% |
| MYRIAD GENETICS INC | 10 | Q1 2023 | 2.3% |
| HARBOR CUSTOM DEVELOPMENT IN | 10 | Q3 2023 | 0.1% |
| CRINETICS PHARMACEUTICALS IN | 9 | Q3 2023 | 4.1% |
| CTI BIOPHARMA CORP | 9 | Q1 2023 | 2.6% |
| POLISHED COM INC | 9 | Q2 2023 | 3.4% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Marpai, Inc. | April 26, 2023 | 1,805,327 | 6.2% |
| Astria Therapeutics, Inc. | February 14, 2023 | 1,355,372 | 5.0% |
| HyreCar Inc. | February 14, 2023 | 1,688,120 | 5.6% |
| Muscle Maker, Inc. | February 14, 2023 | 2,888,085 | 5.0% |
| NeuroBo Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| PALISADE BIO, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| 1847 Goedeker Inc. | February 14, 2022 | 6,103,824 | 5.0% |
| BioRestorative Therapies, Inc. | February 14, 2022 | 200,000 | 5.0% |
| BriaCell Therapeutics Corp. | February 14, 2022 | 900,000 | 4.7% |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. | February 14, 2022 | 363,000 | 5.0% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-08 |
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.